Correlation Between PDS Biotechnology and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and X4 Pharmaceuticals, you can compare the effects of market volatilities on PDS Biotechnology and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and X4 Pharmaceuticals.
Diversification Opportunities for PDS Biotechnology and X4 Pharmaceuticals
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between PDS and XFOR is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between PDS Biotechnology and X4 Pharmaceuticals
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 2.74 times less risky than X4 Pharmaceuticals. The stock trades about -0.17 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 52.00 in X4 Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of 14.23 from holding X4 Pharmaceuticals or generate 27.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. X4 Pharmaceuticals
Performance |
| Timeline |
| PDS Biotechnology Corp |
| X4 Pharmaceuticals |
PDS Biotechnology and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and X4 Pharmaceuticals
The main advantage of trading using opposite PDS Biotechnology and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges |